细胞周期减弱和DNA损伤响应转录组特征和过度表现的细胞粘附过程意味着低风险骨髓质瘤瘤患者的进展加速
Monika Kaisrlikova1, David Kundrat1, Pavla Koralkova2,3
1Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
International journal of cancer
|January 5, 2024
概括
较低风险骨髓质瘤 (MDS) 的加速进展与抑制的DNA损伤反应 (DDR) 和减少CD34+细胞的细胞分化有关. 这一发现可能会改善对MDS患者的风险评估.
科学领域:
- 血液学 血液学 血液学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 骨髓发育性瘤 (MDS) 的分类依赖于急性骨髓性白血病的转变风险.
- 一些较低风险的MDS (LR-MDS) 患者经历了快速进展,挑战了预后.
- 了解加速LR-MDS进展的转录组水平机制至关重要.
研究的目的:
- 研究LR-MDS加速进展背后的转录组水平机制.
- 识别潜在的生物标志物和基因特征,以预测LR-MDS进展.
主要方法:
- 来自LR-MDS患者的CD34+细胞的RNA测序,按进展分层.
- 差异基因表达分析用于比较非进展 (stMDS) 和进展 (prMDS) 组.
- 路径分析和生物标记物识别,包括19基因DNA损伤反应 (DDR) 签名.
主要成果:
- 在stMDS和prMDS组之间发现了845个差异表达的基因.
- prMDS CD34+细胞显示细胞周期下调,DNA损伤反应 (DDR) 和能量代谢途径,细胞粘附上调.
- 在prMDS中注意到异常拼接, lncRNA表达的增加和瘤基因 (ZEB1,NEK3) 的过度表达.
- 一个19基因的DDR签名证明了LR-MDS进展的显著预测能力.
结论:
- 加快的LR-MDS进展与静止状细胞状态,减少血统分化和CD34+细胞中抑制的DDR有关.
- 减弱的DDR相关基因表达特征可以完善LR-MDS患者的风险评估.
- ZEB1和NEK3可以作为LR-MDS进展的新生物标志物.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
DNA Damage can Stall the Cell Cycle
9.2K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.2K
Negative Regulator Molecules
35.4K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K


